SEC Form 4 · accession 0001125345-18-000042
MACROGENICS INC · MGNX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott Koenig
Officer — President and CEO · Director
Period of report
Mar 2, 2018
Accepted (ET)
Mar 6, 2018 · 5:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001125345
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee stock option (right to buy)F1 | $28.94 | Mar 2, 2018 | A | 225,000 | A | — | Mar 2, 2028 | Common Stock | 225,000 | 225,000 | D |
Explanation of responses
- F112.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter.